Albright to Lead Nexell Therapeutics
- Share via
Dow Jones
Nexell Therapeutics Inc. said Wednesday that William A. Albright Jr. has been named president and chief operating officer of the Irvine medical company.
Albright replaces L. William McIntosh, who will leave the management team but continue to advise the company as a consultant and a director.
Albright had been Nexell’s senior vice president and chief financial officer. The company develops cell therapies and diagnostics for cancer, autoimmune, metabolic and genetic diseases.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
